 |
|
|
|
BC00432
Multiple organ tumor and adjacent normal tissue array, 39 cases/43 cores
|
|
| Microarray Panel: | Multiple organ tumor and adjacent normal tissue microarray, 18 types of tumor (bone marrow, breast, cerebrum colon, esophagus, kidney, liver, lung, nose, ovary, pancreas, prostate, skin, spleen, stomach, striated muscle, testis, thyroid and uterine cervix), single core per case |
| Cores: | 43 |
|
| Cases: | 39 |
| Layout: | 8 cols × 6 rows |
| Core Diameter: | 1 mm |
| Thickness: | 5 µm | | Quality Control: | Anti-Actin confirmed | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. |
*Tissue Microarray Slide Types:
- Unstained: unstained
paraffin
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Microarray Panel Display | Legend: | Bon - Bone marrow,
Bre - Breast,
Cer - Cerebrum,
Col - Colon,
Eso - Esophagus,
Kid - Kidney,
Liv - Liver,
Lun - Lung,
Nos - Nose,
Ova - Ovary,
Pan - Pancreas,
Pro - Prostate,
Ski - Skin,
Spl - Spleen,
Sto - Stomach,
Str - Striated muscle,
Tes - Testis,
Thr - Thyroid,
Ute - Uterine cervix
 - Benign tumor,
 - Hyperplasia,
 - Malignant tumor,
 - NAT
|
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Type † |
|
A1 |
1 |
F |
46 |
Cerebrum |
Astrocytoma |
2–3 |
Malignant |
|
A2 |
2 |
M |
46 |
Cerebrum |
Meningioma |
– |
Benign |
|
A3 |
3 |
M |
39 |
Cerebrum |
Caner adjacent normal brain tissue |
– |
NAT |
|
A4 |
4 |
F |
76 |
Thyroid |
Papillary carcinoam |
– |
Malignant |
|
A5 |
5 |
F |
28 |
Thyroid |
Adenoma |
– |
Benign |
|
A6 |
6 |
F |
48 |
Thyroid |
Cancer adjacent normal thyroid tissue |
– |
NAT |
|
A7 |
7 |
F |
63 |
Esophagus |
Squamous cell carcinoma |
2 |
Malignant |
|
A8 |
8 |
F |
63 |
Esophagus |
Cancer adjacent normal esophageal tissue (fibrous tissue and smooth muscle) of No. 07 |
– |
NAT |
|
B1 |
9 |
M |
52 |
Nose |
Nasopharyngeal carcinoma |
– |
Malignant |
|
B2 |
10 |
M |
56 |
Stomach |
Adenocarcinoma |
2 |
Malignant |
|
B3 |
11 |
M |
56 |
Stomach |
Cancer adjacent normal gastric tissue of No. 10 |
– |
NAT |
|
B4 |
12 |
M |
66 |
Colon |
Adenocarcinoma |
2 |
Malignant |
|
B5 |
13 |
M |
66 |
Colon |
Cancer adjacent normal colonic tissue of No.12 |
– |
NAT |
|
B6 |
14 |
F |
56 |
Liver |
Hepatocellular carcinoma |
3 |
Malignant |
|
B7 |
15 |
M |
38 |
Liver |
Cirrhosis of liver |
– |
Hyperplasia |
|
B8 |
16 |
M |
63 |
Liver |
Cancer adjacent normal hepatic tissue |
– |
NAT |
|
C1 |
17 |
M |
49 |
Pancreas |
Duct adenocarcinoma (pancreatic tissue) |
– |
Malignant |
|
C2 |
18 |
F |
36 |
Pancreas |
Cancer adjacent normal pancreatic tissue |
– |
NAT |
|
C3 |
19 |
F |
56 |
Lung |
Adenocarcinoma |
1–2 |
Malignant |
|
C4 |
20 |
M |
58 |
Lung |
Squamous cell carcinoma |
2 |
Malignant |
|
C5 |
21 |
M |
57 |
Lung |
Cancer adjacent normal pulmonary tissue |
– |
NAT |
|
C6 |
22 |
F |
47 |
Breast |
Invasive ductal carcinoma |
2 |
Malignant |
|
C7 |
23 |
F |
33 |
Breast |
Adenoma |
– |
Benign |
|
C8 |
24 |
F |
50 |
Breast |
Cancer adjacent normal breast tissue |
– |
NAT |
|
D1 |
25 |
F |
38 |
Kidney |
Clear cell carcinoma |
1 |
Malignant |
|
D2 |
26 |
F |
38 |
Kidney |
Cancer adjacent normal renal tissue of No. 25 |
– |
NAT |
|
D3 |
27 |
F |
53 |
Uterus |
Adenocarcinoma endometrium |
2 |
Malignant |
|
D4 |
28 |
F |
62 |
Uterine cervix |
Squamous cell carcnoma |
2 |
Malignant |
|
D5 |
29 |
F |
42 |
Uterine cervix |
Cancer adjacent normal endometrial tissue |
– |
NAT |
|
D6 |
30 |
F |
47 |
Ovary |
Serous cystadenocarcinoma |
2 |
Malignant |
|
D7 |
31 |
F |
44 |
Ovary |
Serous papillary cystadenoma |
– |
Benign |
|
D8 |
32 |
F |
53 |
Ovary |
Cancer adjacent normal ovarial tissue |
– |
NAT |
|
E1 |
33 |
M |
75 |
Prostate |
Adenocarcinoma |
2 |
Malignant |
|
E2 |
34 |
M |
73 |
Prostate |
Hyperplasia |
– |
Hyperplasia |
|
E3 |
35 |
M |
32 |
Testis |
Seminoma |
– |
Malignant |
|
E4 |
36 |
M |
16 |
Bone |
Osteosarcoma of right femur |
– |
Malignant |
|
E5 |
37 |
M |
56 |
Bone marrow |
Cancer adjacent normal bone marrow tissue |
– |
NAT |
|
E6 |
38 |
F |
9 |
Spleen |
Cancer adjacent normal splenic tissue |
– |
NAT |
|
E7 |
39 |
M |
20 |
Striated muscle |
Pleomorphic rhabdomyosarcoma of left shoulder |
– |
Malignant |
|
E8 |
40 |
M |
50 |
Striated muscle |
Cancer adjacent normal skeletal muscle tissue |
– |
NAT |
|
F1 |
41 |
F |
46 |
Skin |
Malignant melanoma of thigh |
– |
Malignant |
|
F2 |
42 |
M |
52 |
Skin |
Squamous cell carcinoma of scalp |
1 |
Malignant |
|
F3 |
43 |
F |
49 |
Skin |
Cancer adjacent normal dermatic tissue |
– |
NAT |
† For precise diagnosis, refer to pathology description.
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
|
|
